Fecal Transplant With Anti-Inflammatory Diet Yields Remissions in UC
(MedPage Today) -- Multidonor fecal microbiota transplantation coupled with an anti-inflammatory diet (FMT-AID) induced remissions in patients with mild-to-moderate ulcerative colitis when added to standard medical therapy, a randomized trial in... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - August 18, 2022 Category: Gastroenterology Source Type: news
AI Accurately Classifies Endoscopic Severity in Ulcerative Colitis AI Accurately Classifies Endoscopic Severity in Ulcerative Colitis
This artificial intelligence model could distinguish all four Mayo endoscopic categories and even end intra- and interobserver variation.MDedge News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - August 12, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
Gut Bacteria Post-COVID; UC Remission Prediction; UC Flares with Stress
(MedPage Today) -- Gut dysbiosis lingered on at an average of 14 months' follow-up after COVID-19 among patients in Hong Kong. (Gut)
For ulcerative colitis, fecal calprotectin levels weren't good at identifying disease activity but could point... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - August 12, 2022 Category: Gastroenterology Source Type: news
Crohn's, Colitis Tied to Higher-Risk Pregnancies
TUESDAY, Aug. 9, 2022 -- Women who have inflammatory bowel disease (IBD) should work with a doctor to get it into remission before pregnancy, a new study indicates.
Researchers found that women with Crohn ' s disease and ulcerative colitis, both types... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 9, 2022 Category: General Medicine Source Type: news
GPs could soon offer quick scan to check for serious bowel conditions during routine appointments
The portable device can help doctors spot early problems such as ulcerative colitis - a painful disease that causes ulcers in the colon - and even cancers. (Source: the Mail online | Health)
Source: the Mail online | Health - August 6, 2022 Category: Consumer Health News Source Type: news
Rethinking Histology as Treatment Target in Ulcerative Colitis Rethinking Histology as Treatment Target in Ulcerative Colitis
Histologic activity should not be used as a treatment target in ulcerative colitis, as it seems to have no impact on the risk of clinical relapse, suggests a large prospective study.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - August 4, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
Race, Insurance Status Linked to Poor Outcomes in Hospitalized UC Patients
(MedPage Today) -- Race/ethnicity and insurance status were associated with poor outcomes among hospitalized patients with ulcerative colitis (UC), according to a nationally representative cohort study.
Among nearly 35,000 people included in the... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - August 3, 2022 Category: Gastroenterology Source Type: news
STELARA ® (ustekinumab) Approved by the U.S. Food and Drug Administration to Treat Pediatric Patients with Active Psoriatic Arthritis
HORSHAM, PENNSYLVANIA, August 1, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved STELARA® (ustekinumab) for the treatment of pediatric patients six years of age and older with active psoriatic arthritis (PsA). This rare disease that resembles adult PsA affects five to eight percent of children and adolescents with chronic inflammatory arthritis.*1-7 Two of the four indications for STELARA now include pediatric patients, further expanding its treatment profile since the first approval in 2009 for adults living with moderate...
Source: Johnson and Johnson - August 1, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news
Fecal Transplant in UC; Cancer Surveillance Lacking in Cirrhosis; Undiagnosed Celiac
(MedPage Today) -- Researchers believe they've identified two more reasons why fecal microbiota transplants from certain donors more often induce ulcerative colitis (UC) remissions. (Gut)
AbbVie announced that it is seeking FDA approval for a... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - July 28, 2022 Category: Gastroenterology Source Type: news
Quicker Remission With Tofacitinib vs Vedolizumab in Ulcerative Colitis: Study Quicker Remission With Tofacitinib vs Vedolizumab in Ulcerative Colitis: Study
Tofacitinib achieves higher clinical and biochemical remission rates than vedolizumab for patients with anti-TNF-exposed ulcerative colitis, although the effect diminishes over time, say Dutch scientists.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - July 11, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
Crohn's Disease vs. Ulcerative Colitis
Title: Crohn ' s Disease vs. Ulcerative ColitisCategory: Diseases and ConditionsCreated: 7/24/2017 12:00:00 AMLast Editorial Review: 7/8/2022 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - July 8, 2022 Category: Nutrition Source Type: news
Study Uncovers Strong Links Between Depression and Crohn's, Colitis
MONDAY, June 6, 2022 -- New research points to a compelling interplay between inflammatory bowel disease (IBD) and depression.
IBD includes Crohn ' s disease and ulcerative colitis. In addition to the physical pain that these illnesses can inflict... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 6, 2022 Category: General Medicine Source Type: news
Ulcerative colitis can be eliminated in just three months thanks to daily tablet
Once-a-day tablet etrasimod treats the condition ulcerative colitis by binding to immune cells and preventing them from mistakenly attacking healthy tissue in the lining of the gut. (Source: the Mail online | Health)
Source: the Mail online | Health - June 4, 2022 Category: Consumer Health News Source Type: news
What Happens When You Have Ulcerative Colitis?
Title: What Happens When You Have Ulcerative Colitis?Category: Diseases and ConditionsCreated: 6/3/2022 12:00:00 AMLast Editorial Review: 6/3/2022 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - June 3, 2022 Category: Nutrition Source Type: news
New Data Show Patients Treated with First-in-Class TREMFYA ® (guselkumab) Achieve Durable Efficacy Across Joint and Axial Symptoms of Active Psoriatic Arthritis Through Two Years
SPRING HOUSE, PENNSYLVANIA, June 1, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from Phase 3 studies demonstrating patients treated with TREMFYA® (guselkumab) achieved consistent, long-term efficacy through two years across the domains of active psoriatic arthritis (PsA) – including joint, skin, enthesitis,a dactylitis,b spinal pain and disease severityc endpoints – irrespective of baseline characteristics.1 Further analyses showed TREMFYA also provided patients with sustained improvements in measures of health-related quality of life (HRQoL), including fatigue, pain...
Source: Johnson and Johnson - June 1, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
